FEMY: Gunggunge utang jangka dawa Femasys Inc

Femasys Inc. (FEMY) is pioneering reproductive health solutions by offering an affordable alternative to IVF through its FemaSeed sperm transport system. The company is currently scaling the implementation of its non-drug treatment systems, while the separate_debt_long metric stands at 0.01. This price chart provides a clear supplement to the analysis of the company, which develops painless diagnostic and contraceptive tools for use in standard clinics.

FEMY Femasys Inc.: Utang jangka dawa perusahaan ing interval 04.07.2022 - 29.10.2026

Rincian analitis perusahaan Femasys Inc.

- rega lan prakiraan konsensus rega:

Kurs saham femasys.com|FEMY - Prakiraan konsensus analis

- data kapitalisasi pasar:

Kapitalisasi pasar Femasys|FEMY - Nilai Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi saben Saham Femasys|FEMY - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku femasys.com|FEMY - Aset Agregat Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas Femasys Inc.|FEMY - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Femasys Corporation|FEMY - Gunggung utang perusahaan|Utang-utang marang aset resik Femasys|FEMY - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Femasys

Analisis umum perusahaan:femasys.com (FEMY)

Long-term debt captures the aggregate of obligations with maturities exceeding one year, allowing investors to track borrowing rates in real time before official reports are released. Analyzing the long-term debt chart helps differentiate expansion from cash flow gaps, which is critical for Femasys Inc. (FEMY) while navigating costly FDA certification stages and protecting FemaSeed patents.

Analisis pesaing